Autophagy couteracts weight gain, lipotoxicity and pancreatic ß-cell death upon hypercaloric pro-diabetic regimens by Fernández Fernández, Álvaro et al.
OPEN
Autophagy couteracts weight gain, lipotoxicity and
pancreatic β-cell death upon hypercaloric pro-diabetic
regimens
Álvaro F Fernández1,2, Clea Bárcena2, Gemma G Martínez-García1,3, Isaac Tamargo-Gómez1,2,3, María F Suárez1,3,
Federico Pietrocola4,5,6, Francesca Castoldi4,5,6,7, Lorena Esteban8, Elena Sierra-Filardi8, Patricia Boya8, Carlos López-Otín2,
Guido Kroemer4,5,6,9 and Guillermo Mariño*,1,3
In the last years, autophagy has been revealed as an essential pathway for multiple biological processes and physiological
functions. As a catabolic route, autophagy regulation by nutrient availability has been evolutionarily conserved from yeast to
mammals. On one hand, autophagy induction by starvation is associated with a significant loss in body weight in mice. Here, we
demonstrate that both genetic and pharmacological inhibition of the autophagy process compromise weight loss induced by
starvation. Moreover, autophagic potential also impacts on weight gain induced by distinct hypercaloric regimens. Atg4b-deficient
mice, which show limited autophagic competence, exhibit a major increase in body weight in response to distinct obesity-
associated metabolic challenges. This response is characterized by the presence of larger adipocytes in visceral fat tissue,
increased hepatic steatosis, as well as reduced glucose tolerance and attenuated insulin responses. Similarly, autophagy-deficient
mice are more vulnerable to experimentally induced type-I diabetes, showing an increased susceptibility to acute streptozotocin
administration. Notably, pharmacological stimulation of autophagy in wild-type mice by spermidine reduced both weight gain and
obesity-associated alterations upon hypercaloric regimens. Altogether, these results indicate that systemic autophagic activity
influences the resilience of the organism to weight gain induced by high-calorie diets, as well as to the obesity-associated features
of both type-1 and type-2 diabetes.
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Autophagy is well known to control the mass of individual cells
because it constitutes the most efficient pathway for the
degradation of cytosolic proteins and protein aggregates,1 as
well as the sole pathway for the digestion and recycling of
cytoplasmic organelles.2 Thus, in response to nutrient starva-
tion or different external stimuli, cells reduce their biomass in
an autophagy-dependent fashion,3–5 accessorily degrading
macromolecules into the building blocks of adaptive
responses, as well as into substrates of energy-producing
reactions.6
This catabolic process is one of the prime responses to
nutrient depletion at the whole-body level. In response to
starvation, mice manifest a major reduction in body weight
(~20% in 48 h) as they mount a major autophagic response
that is detectable in most if not all organs of the body.7 In this
context, it is well known that autophagy is required for the
healthspan- and lifespan-extending effects of caloric restric-
tion, at least in model organisms.8 Indeed, the knockout of
genes indispensable for autophagy is compatible with life in
yeast, nematodes or flies, although the resulting autophagy
deficiency reduces the overall fitness of these organisms,
compromises their longevity and abolishes the positive effects
of caloric restriction on the aging process and life expectancy.8
In mice, the loss of essential autophagy genes either results
into neonatal death shortly after birth9–11 or causes embryonic
lethality due to developmental defects.12–15 This implies that
the impact of autophagy on caloric restriction has not been
fully addressed in mammals, due to the lack of appropriate
animal models.
Several mammalian autophagy genes, as Atg3, Atg5, Atg7,
Ambra1, FIP200 and Becn1, among others, operate in a non-
redundant way in central hubs of the autophagic pathway,
meaning that their knockout causes a complete (and lethal)
defect in autophagy.16 In contrast to the former cases, mammals
possess several orthologs of yeast Atg4 protease that together
form the Atg4 protein family, composed by ATG4A, ATG4B,
ATG4C and ATG4D.17,18 Hence, the knockout of one single
member of the family, for instance Atg4b, is compatible with a
close-to-normal development before and beyond birth.19,20
Nonetheless, atg4b− /− mice exhibit a significant reduction of
their autophagic potential in multiple distinct organs. Thus,
autophagic flux, as well as the depletion of the autophagic
substrate SQSTM1/p62, are diminished in both fed and starved
atg4b− /− mice compared with wild-type (WT) littermates.19
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Recently, we observed that induction of autophagy by a
novel caloric restriction mimetic, hydroxycitrate, induces
weight loss in control WT mice, yet failed to do so in atg4b− /−
animals.21,22 These findings established a precedent indicat-
ing that autophagy might control body mass in conditions as
starvation and prompted us to investigate the impact of
systemic autophagy reduction on the control of weight gain
induced by high-calorie regimens. Here, we report that both
genetic and chemical attenuation of autophagic flux account
for a reduction in starvation-induced weight loss. Moreover,
autophagy deficiency at the whole-body level predisposes to
obesity, hyperinsulinemia and insulin intolerance upon diverse
metabolic challenges, and also increases the severity of
experimentally induced type-I diabetes. Finally, we show that
the detrimental effects of hypercaloric diets in WTmice can be
mitigated by pharmacological induction of autophagy in vivo,
delineating new promising therapeutic strategies against
obesity-related pathologies.
Results
Reduced starvation-induced weight loss in autophagy-
deficient mice. atg4b− /− Mice generated by crossing
heterozygous Atg4b+/- parents are born at the expected
Mendelian frequency and appear phenotypically normal, with
the sole exception that 15–20% of the mice exhibit perturbed
equilibrioception due to deficient otoconial biogenesis.19 In
response to starvation for 24–48 h, such mice also exhibit a
clear defect in the induction of autophagy in multiple distinct
organs.19 This autophagy defect of atg4b− /− mice was
associated to a reduced weight loss upon fasting when
compared with WT littermates (Figure 1a). Similarly, suppres-
sion of starvation-induced autophagy by injection of the
autophagy inhibitor α-ketoglutarate precursor, dimethyl
α-ketoglutarate,21 blunted weight loss in WT mice
(Figure 1a). Hence, different methods to inhibit starvation-
induced autophagy (deficiency of Atg4b, as well as pharma-
cological inhibition with the anaplerotic substrate α-ketoglu-
tarate) have a similar effect on weight reduction.
Excessive weight gain of autophagy-deficient mice fed
with hypercaloric diets. In order to further analyze a
possible role for systemic autophagy in weight regulation,
we next decided to test whether the partial but systemic
autophagy impairment of atg4b− /− mice could affect body
weight gain under hypercaloric diets. As shown by area under
the curve (AUC) comparison, adult (60 day-old) atg4b− /−
mice and littermate WT controls exhibited a similar age-
associated weight gain over the subsequent 120 days if fed
standard chow ad libitum (Figure 1b). In contrast, if atg4b− /−
mice were fed a Western style high-fat diet, they exhibited a
statistically significant increase in weight gain, as compared
with WT animals (Figure 1c). Similarly, there was also a
significant difference in the response of atg4b− /− and WT
mice to continuous supplementation of the drinking water
with 30% sucrose, a model of experimentally induced
metabolic syndrome. In WT mice, this regimen fails to induce
a major weight gain, yet causes hepatic steatosis and insulin
resistance.23,24 Unexpectedly, but in accord with our previous
results, atg4b− /− mice exhibited a steady weight gain that
reached ~50% after 100 days of sucrose treatment, which
was significantly higher that what was observed in WT
controls under this same regimen (Figure 1d).
Although atg4b− /− and WT mice were undistinguishable
with respect to the mass and size of adipocytes (Figure 2a),
atg4b− /−mice that received a high-fat diet or sweetened water
exhibited amore abundant subcutaneous and visceral fat than
WT controls, with an abnormal increase in the mean diameter
of adipocytes (Figures 2c and e). Moreover, atg4b− /− mice
only showed increased hepatic steatosis with respect to
controls when challenged with high-fat diet or sugar-enriched
water (Figures 2d and f), as these differenceswere not present
when mice were fed standard diet (Figure 2b). This suggests
that the observed increase of fat accumulation is not limited to
white adipose tissue, but is rather a consequence of a
systemic obesity-linked metabolic alteration. Interestingly,
circulating values of alanine and aspartate aminotransferases
in atg4b− /− mice were comparable to those from WT mice in
all different experimental settings (Supplementary Figures 1A
andB). This indicates thatAtg4b deletion itself does not lead to
liver damage, contrasting with previous studies in which liver
autophagy is totally impaired.25,26 Moreover, plasma values of
certain pro-inflammatory cytokines and chemokines, including
IFNγ or IL-6, were slightly augmented in atg4b− /− mice when
subjected to high-calorie regimens, in accord with previous
studies linking higher pro-inflammatory responses the
absence of ATG4B,20 although these differences failed to
reach statistical significance (Supplementary Figure 1C).
Irrespectively of the aforementioned observations regarding
circulating parameters, WTand atg4b− /−mice showed similar
degrees of inflammatory infiltration both in liver and adipose
tissue either untreated or upon high-calorie regimens
(Supplementary Figures 1D–I). Thus, increased meta-
inflammation is likely not a major cause for the higher obesity
observed in autophagy-deficient mice, which may be mainly
linked to the reduced autophagic flux that atg4b− /− mice
manifest in all tissues,19 including liver and white fat
(Figures 2g and h).
Obesity-related biochemical features in autophagy-
deficient mice. Intrigued by the aforementioned observa-
tions, we determined obesity-associated biochemical fea-
tures in either unchallenged or treated atg4b− /− mice and
their WT controls. As shown by AUC comparison, both
glucose tolerance test (GTT) and insulin tolerance test (ITT)
showed no significant differences between untreated WTand
autophagy-deficient mice (Figures 3a and b). However, upon
challenge with high-fat diet or sucrose-enriched water, mutant
mice maintained significantly higher glucose levels for a
longer period than their corresponding WT controls during the
GTT (Figures 3c and e). Moreover, when fed with hyperca-
loric regimens, the decrease in glucose level induced by
insulin injection was significantly attenuated in atg4b− /−
animals compared with WT controls (Figures 3d and f). When
unchallenged, atg4b− /− mice show normal circulating glu-
cose, insulin, leptin or adiponectin levels (data not shown). In
contrast, upon high-fat chow feeding or sucrose treatment,
autophagy-incompetent mice exhibit significant differences in
many of these parameters. Specifically, leptin serum levels
Autophagic activity controls body weight
ÁF Fernández et al
2
Cell Death and Disease
were higher and adiponectin concentrations were lower in
atg4b− /− mice than in WT controls (Figures 4a–d). Although
blood glucose levels were slightly higher in mutant mice upon
hypercaloric diets, the differences were not statistically
significant (Figures 4e and g). In contrast, circulating insulin
concentrations were substantially higher in atg4b− /− mice
subjected to high-calorie regimens, as compared with WT
controls, which may account for their reduced insulin
sensitivity (Figures 4f and h). The surge in circulating insulin
levels was accompanied by an increase in the size and
number of pancreatic islets, as well as an increase in relative
β-cell mass in atg4b− /− mice subjected to high-calorie diets.
Interestingly, this increase in the number and size of β-cells
patches was not detected in the corresponding age-matched
WT littermates (Supplementary Figure 2).
Reduced metabolism of autophagy-deficient mice fed
with hypercaloric diets. To understand the cause of the
obesity-linked alterations observed in Atg4b-deficient mice, we
examined daily food intake and energy expenditure by means
of the Oxymax/CLAMS system. Interestingly, the high-fat or
sugar-induced obesity of atg4b− /− mice could neither be
attributed to increased caloric intake nor to a significantly
reduced locomotor activity. Surprisingly, atg4b− /− mice tended
to reduce their food and water intake under high-fat diet or
sucrose treatment, although this trend did not reach statistical
significance (Supplementary Figure 3). However, atg4b− /−
mice did show both lower oxygen consumption (VO2), and
lower carbon dioxide release (VCO2), when subjected to
high-calorie regimens (Figures 5a–d), which was not observed
under standard diet (Supplementary Figures 4A and B). This
led to a decrease of energy expenditure in atg4b− /− mice, as
compared with WT animals, when subjected to both high-
calorie regimens (Figures 5e and f). However, no difference in
energy expenditure was observed in ad libitum fed atg4b− /−
and WT mice receiving the standard chow (Supplementary
Figure 4C). This alteration of the metabolic rate occurred
without changes in the respiratory exchange ratio (RER),
which reflects the relative use of carbohydrates versus lipids
as a source of energy (Supplementary Figures 4D–F). These
results suggest that reduced energy expenditure could be
contributing to the observed increase of weight gain in
autophagy-deficient mice.
Together, our results indicate that the partial and systemic
reduction of autophagic activity of atg4b− /−mice predisposes
to high-fat and sucrose-induced obesity upon a similar, or even
lower, calorie intake, by reducing energy expenditure, oxygen
consumption and carbon dioxide release.
Autophagy-deficient mice are more susceptible to
experimentally induced type-I diabetes. In order to test
whether the partial and systemic autophagy impairment of
Atg4b-null mice might also predispose to experimentally
induced type-I diabetes, we next decided to treat WT and
autophagy-deficient mice with streptozotocin (STZ), Thus,
mice were administered a single dose of STZ and after
3 days, blood glucose levels and glucose tolerance were
evaluated. In concordance with our previous results,
Figure 1 Effects of systemic autophagy deficiency on weight changes induced by starvation and hypercaloric dietary regimens. (a) atg4b− /−Mice show reduced weight loss
(depicted as the percentage of the initial weight) upon either 24- or 48-h of starvation, as compared with age-matched WT littermates. This was also observed in control mice
treated with the autophagy inhibitor dimethyl-α-ketoglutarate (DMKG). (b) Weight curves of WT or atg4b− /− mice fed ad libitum with standard rodent diet without any
supplementation in drinking water. Bar graph shows area under the curves (AUC). (c) Weight curves of WTor atg4b− /−mice fed ad libitum with a high-fat diet containing 42% fat
and without any supplementation in drinking water. Bar graph shows AUC. (d) Weight curves of WTand atg4b− /− mice fed ad libitum with standard rodent diet with 30% sucrose
supplementation in drinking water. Bar graph shows AUC. For starvation-related experiments in mice, at least 6 animals per genotype/condition were used. For specific diets
experiments in mice, at least 12 animals per genotype/condition were used. *P-valueo0.05 and **P-valueo0.01 in two-tailed student’s t-test for each of the depicted points
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Atg4b-null mice showed a significant increase in blood
glucose levels, as compared with the corresponding controls,
as well as a reduced performance in the GTT (Figures 6a
and b). These alterations were progressively exacerbated in
autophagy-deficient mice and finally resulted in an increased
mortality (60%), as compared with the corresponding controls
(10%) (Figure 6c). Interestingly, STZ-treated atg4b− /− mice
showed clear signs of hepatosteatosis, which was hardly
observed in equally treated WT mice (Figure 6d). Moreover,
histological analyses of pancreas from STZ-treated mice
revealed that loss of β-cell islets integrity was more
pronounced in mutant mice, which showed increased signs
of necrotic cell death and a reduced presence of healthy
insulin-producing β-cells (Figures 6e and f). Altogether, these
data show that the partial and systemic autophagy defect of
Atg4b-null mice not only predisposes to diet-induced obesity,
but also renders them more prone to pancreatic β-cell
damage, also predisposing them to environmentally induced
type-I diabetes.
Induction of autophagy by spermidine prevents weight
gain induced by high-fat diet. Prompted by our results
pointing to a protective role for stress-induced autophagy
against different types of metabolic disturbances, we decided
to evaluate whether therapeutic induction of autophagy would
counteract the detrimental effects of pro-obesity regimens,
including weight gain and its associated metabolic alterations
observed upon hypercaloric challenge. To this aim, WT mice
fed with Western style high-fat diet were given a daily dose of
spermidine, a polyamine which induces autophagy
in vivo.22,27 Interestingly, spermidine-treated mice showed a
significant reduction of weight gain, as compared with the
corresponding high-fat diet fed controls (Figure 7a). In fact,
spermidine-treated mice showed reduced visceral fat than
WT controls, together with a significant decrease in the mean
diameter of adipocytes (Figure 7b). Consistently, high-fat fed
spermidine-treated mice showed significantly reduced hepa-
tosteatosis when compared with untreated control mice fed
with the same diet (Figure 7c). Moreover, spermidine-treated
mice were significantly more glucose tolerant and insulin
sensitive than untreated mice, when challenged with GTTand
ITT respectively (Figures 7d and e). Several works from
different labs have previously shown that spermidine treat-
ment is able to increase autophagic flux in vivo in a variety of
tissues, including metabolically relevant tissues as liver or
skeletal muscle, but did not analyze the effect of spermidine
treatment in adipose tissue.27,28 As shown in Figure 7f,
spermidine treatment was able to increase autophagic flux in
white adipose tissue, as measured by increased LC3
lipidation accompanied by decrease in SQSTM1/p62 levels.
Interestingly, the amelioration of obesity-linked parameters
observed in spermidine-treated mice was associated with
increased expression of ATG4B protein in spermidine-treated
mice, which supports our results from Atg4b-null mice
Figure 2 Obesity-related features of atg4b− /− mice fed with hypercaloric regimens. (a) Left, representative pictures of adipocytes from H&E sections of white adipose tissue
in untreated WTand atg4b− /− mice. Right, quantification of the data. (b) Left, representative pictures from H&E sections (left) and Oil Red staining (right) of livers from untreated
WTand atg4b− /− mice showing the absence of hepatic steatosis. (c) Left, representative pictures of adipocytes from H&E sections of white adipose tissue in WTand atg4b− /−
mice upon high-fat diet. Right, quantification of the data. (d) Left, representative pictures from H&E sections (left) and Oil Red staining (right) of livers from WTand atg4b− /−mice
upon high-fat diet showing an increase of hepatic steatosis in atg4b− /−mice. Right, quantification of the data. (e,f) Representation of equivalent data to those shown in c and d for
sucrose-treated WT and atg4b− /− mice. (g,h) Immunoblotting analyses of ATG4B, SQSTM1/p62 and LC3B in white adipose (g) and liver (h) tissues from mice subjected for
60 days to high-fat diet, showing the absence of ATG4B protein, the reduction of autophagosome-associated LC3B-II and the accumulation of the specific autophagic substrate
SQSTM1/p62, all indicative of reduced autophagic flux. Graph bars show quantification of the data depicted in Immunoblotting panels. *P-valueo0.05 in two-tailed student’s
t-test. Scale bars, 30 μm
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Figure 3 Glucose- and insulin-tolerance in atg4b− /− mice fed with hypercaloric regimens. (a) Intraperitoneal glucose tolerance test (IPGTT), and (b) intraperitoneal insulin
tolerance test (IPITT), in untreated WTand atg4b− /− mice (n= 6). (c,d) Intraperitoneal glucose test tolerance (IPGTT), and intraperitoneal insulin tolerance test (IPITT), in WT
and atg4b− /− mice upon high-fat diet (n= 6). (e,f) Equivalent analyses in sucrose-treated WTand atg4b− /− mice (n= 6). Bar graph shows area under the curves (AUC). Error
bars represent means±S.E.M. *P-valueo0.05
Figure 4 Analysis of obesity-linked biochemical parameters in atg4b− /− mice. (a-d) Circulating levels of leptin (a and c) and adiponectin (b and d) in high-fat fed (a and b)
and sucrose-treated atg4b− /− mice (c and d), as compared with their corresponding age-matched WT controls (n= 6). (e–h) Blood glucose levels (e and g) and plasma insulin
levels (f and h) in in high-fat fed (e and f) and sucrose-treated WT and atg4b− /− mice (g and h). Bars represent means± S.D. (n= 6). *P-valueo0.05
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pointing to a protective anti-obesity role for ATG4B protease
and autophagy pathway in diverse experimental settings.
Taken together, our results show that autophagic potential
may influence propensity to develop different metabolic
pathologies. On one hand, a partial but systemic autophagy
inhibition, as in Atg4b-null mice19 or in aged individuals,8,29
may predispose to obesity or diabetes upon high-calorie
regimens or in circumstances that compromise pancreatic
β-cell homeostasis. On the other hand, stimulation of
autophagic flux may counteract the detrimental effects of
excessive caloric intake associated with Western style
nutritional habits, thus delineating new anti-obesity opportu-
nities based on autophagy stimulation.
Discussion
In the last years, autophagy has emerged as a pivotal pathway
essential for most of cellular functions, either as a basal
housekeeping process or as a stress-induced pro-survival
route. Contrasting with other model organisms, such as
C. elegans or D. melanogaster, in which the disruption of
essential autophagy genes, such as atg7, is compatible with
life,30,31 total autophagy impairment leads to perinatal lethality
in mice.11 To circumvent this limitation, most studies aimed to
unveil the physiological functions of autophagy in mammals
have relied on the analysis of mice in which autophagy was
inactivated in a tissue-specific and/or a temporally-controlled
fashion. These studies have revealed a pivotal role for this
process in distinct metabolically relevant tissues. Specifically,
autophagy impairment upon Atg7 gene deletion in hypotha-
lamic AgRP neurons results in reduced food intake and lean
phenotype,32 whereas deletion of the same gene in hypotha-
lamic pro-opiomelanocortin-producing cells leads to increa-
sed weight gain and reduced metabolic performance.33
Likewise, analyses of β-cell specific Atg7-deficient mice have
revealed an essential role for autophagy in pancreatic islet
homeostasis, in which a total loss of autophagy results in
substantial cell death of β-cells either under standard diet or
upon obesity-promoting regimens.34 Conversely, autophagy
ablation in Atg7-null mice impacts adipose tissue function,
leading to a lean phenotype with decreased white adipose
mass and enhanced insulin sensitivity.35,36 Altogether, these
elegant studies have contributed to understand and dissect
the role of autophagy in many different tissues, including those
that are pivotal for energy homeostasis and metabolism.
However, some of the results yielded by these experimental
approaches may not be related to loss of tissue-specific
functions of autophagy itself, but rather to tissue malfunction
as a consequence of autophagy ablation, due to the house-
keeping nature of basal autophagy. In fact, total impairment of
Figure 5 Analysis of respiration and energy expenditure in atg4b− /− mice fed upon high-calorie regimens. (a) VO2 consumption (ml/kg/hour) during dark phase (12 h) (left)
and area under the curve of the VO2 consumption (right) for WT and Atg4b-null mice upon high-fat diet (n= 4). (b) Same representation as in a for sucrose-treated WT and
Atg4b-null mice. (c,d) VCO2 production for WTand Atg4b-null mice fed with high-fat diet (c), or sucrose treated (d) (n= 4). (e,f) Energy expenditure (Kcal/kg/hour) during dark
phase (12 h) and area under the curve of the energy expenditure (right) for WT and Atg4b-null mice fed with high-fat diet (e), or sucrose treated (f) (n= 4). Data represent
mean± S.E.M. *Po0.05, **Po0.01
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Figure 6 atg4b− /− mice are more prone to streptozotocin-induced type-I diabetes. (a) Blood glucose levels of streptozotocin (STZ)-treated WTand atg4b− /− mice at day 1
and day 3 after STZ injection (n= 8). (b) Intraperitoneal glucose tolerance test (IPGTT) in STZ-treated WTand atg4b− /− mice at day 3. Bar graph shows areas under curve
(AUC) (n= 8). (c) Kaplan–Meier graph of STZ-treated WT and atg4b− /− mice showing a significant increment of mortality in the absence of ATG4B. (n= 8). (d) Left,
representative pictures from H&E sections (left panels) and Oil Red staining (right panels) of livers from STZ-treated WTand atg4b− /− mice at day 3. Right, quantification of the
data. Scale bars, 30 μm. (e) Representative pictures from H&E sections of pancreatic β-cell islets at day 3 after STZ treatment (left). β-cell islets are surrounded by dashed lines.
Necrotic area is marked by an asterisk. Right, quantification of necrotic stage in these samples. Scale bars, 60 μm. (f) Immunofluorescence analysis against insulin showing
specific loss of β-cell in atg4b− /− at day 3 after STZ treatment (left). β-cell islets are surrounded by dashed lines. Right, quantification of the data. Data represent mean±S.E.M.
*P-valueo0.05. Scale bars, 60 μm
Figure 7 Autophagy induction by spermidine protects from the detrimental effects of high-fat diet in wild-type mice. (a) Weight curves of untreated and spermidine-treated WT
mice (spd) fed with high-fat diet (HF) without any supplementation in drinking water. Bar graph shows area under the curves (AUC) (n= 10). (b) Intraperitoneal glucose tolerance
test (IPGTT), and (c) intraperitoneal insulin tolerance test (IPITT), in untreated and spermidine-treated high-fat fed WT mice. Bar graph shows area under the curves (AUC). (d)
Left, representative pictures of adipocytes from H&E sections of white adipose tissue in untreated and spermidine-treated high-fat fed WT mice. Right, quantification of the data.
(e) Left, representative pictures from H&E sections (left panels) and Oil Red staining (right panels) of livers from untreated and spermidine-treated high-fat fed WT mice. Right,
quantification of the data. (f) Left, immuno-blotting analyses of ATG4B, LC3B and SQSTM1/p62 proteins in white adipose tissue extracts from either vehicle-treated or spermidine-
treated WT mice subjected to high-fat diet, showing the effective increase of both ATG4B expression and autophagic flux in spermidine-treated mice. Right, quantification of the
data. Data represent mean±SEM. Left, graph bars showing quantification of the data depicted in immuno-blotting panels. *P-valueo0.05. Scale bars, 30 μm.
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of basal autophagy may compromise cellular fitness and the
metabolic efficacy of affected tissues in a similar way than
tissue-specific ablation of other essential processes would do,
thereby masking specific and physiologically relevant func-
tions of autophagy as an inducible anti-stress response.
In this sense, it has to be noted that very few studies have
addressed the consequences of a reduction (but not a total
impairment) of autophagic activity at the whole-body level.
This is a relevant question, as it is known that autophagic
potential progressively declines as the organism ages8 and
some environmental factors, including pollutants or nanopar-
ticles, interfere with components of the pathway, reducing
autophagic competency in a progressive way.37 The partial
autophagic reduction of atg4b− /−mice is likely more similar to
real pathological conditions in which autophagic degradation
is partially impaired but not totally deactivated. In fact, basal
autophagic activity of atg4b− /− mice is sufficient to achieve a
lifespan almost identical to that of WT mice (our unpublished
observations), with no higher incidence of anymajor pathology
with the exception of low-penetrance early-onset balance
disorder, affecting ~ 25% of Atg4b-null mice. However,
atg4b− /− cells and mice are not able to mount an appropriate
autophagic response when challenged by nutrient
deprivation19 or different autophagy-inducing agents such as
the polyamine spermidine, the polyphenol resveratrol, or the
mTOR inhibitor Torin (Supplementary Figure 5). Hence, the
reduced but not totally impaired autophagy of atg4b− /− mice
likely affects adaptability at the cell, tissue or organism levels,
thus contributing to increase susceptibility to diverse pathol-
ogies, including obesity and other metabolic disturbances
(Figure 8).
ATG4B is one of the four mammalian orthologs of yeast Atg4
protease and cleaves the orthologs of Atg8 (like LC3B or
GABARAP, as well as other proteins from the LC3 and
GABARAP families), removing the carboxy-terminal amino
acids and leaving a glycine residue at the C-terminus.17,38
This cleavage is strictly required for the subsequent lipidation
of the glycine residue, creating phosphatidyl ethanolamine-
conjugated proteins that associate with autophagosomes.39
The sole Atg4 substrates identified thus far are Atg8 orthologs,
suggesting that the physiological role of Atg4 is confined to
autophagy. Thus, our observation that atg4b− /− mice are
prone to both experimentally induced type-I and type-II
diabetes shows for the first time that reduced autophagy
competency, although still sufficient to sustain tissue home-
ostasis in normal conditions, leads to increased sensitivity to
different metabolic challenges, thus predisposing both to diet-
induced obesity as well as to environmentally induced
pancreatic β-cell loss.
Due to the pivotal importance of autophagy pathway for
maintaining the homeostasis of several metabolically relevant
tissues, a combination of multiple factors might underlie the
observed susceptibility to obesity. For instance, atg4b− /−mice
fed upon standard chow neither show signs of increased
hepatosteatosis nor liver damage. This suggests that the
ability of mutant mice to perform lipophagy and other basic
liver functions is sufficient to copewith specific requirements in
this regard. By contrast, when subjected to pro-obesity
regimens, mutant animals show clear signs of hepatostea-
tosis. This may partially derive from insufficient lipophagy if
demands imposed by pro-obesity treatments are too high.
Thus, additional systemic alterations combined with intrinsic
cellular defects might likely account for the increased
susceptibility of atg4b− /− mice to experimentally induced
type-I and type-II diabetes. In any case, it remains a
conundrum which particular organ or organ system is more
affected by autophagy deficiency in the context of obesity-
linked metabolic alterations. Future studies involving the
generation of tissue-specific knockout mice in which the
potential to increase autophagic activity is reduced, while
maintaining sufficient basal activity, as in the case of atg4b− /−
mice, may unveil these incognita. Moreover, our observation
that energy expenditure is significantly reduced in autophagy-
deficient mice upon pro-obesity regimens (but not under
standard chow) may provide new insights in how systemic
autophagic activity influences unexpected aspects of
mammalian physiology.
In summary and despite of the aforementioned caveats, the
present study provides strong arguments in favor of a
mechanistic link between autophagy and weight control. In
this context, it appears logical that prominent measures to
induce autophagy (like spermidine administration or gene
therapy with pro-autophagic transcription factors, such as
TFEB) may inhibit or prevent obesity in vivo.40,41
Materials and Methods
Animals used in this study. The generation of atg4b− /− mice has been
previously described.19 For atg4b− /− experiments, Atg4b-null mice and their
corresponding wild-type (WT) littermates were derived from interbreeding of
heterozygous C57Bl6/129 Sv mice and their genotypes were determined by PCR-
based analysis of tail DNA. Mice were bred under specific pathogen-free conditions.
All experiments were performed with 8- to 12-week-old mice and were approved by
the Committee on Animal Experimentation of Universidad de Oviedo (Oviedo,
Spain). For starvation-associated experiments, food was completely removed from
mice cages, access to water was allowed as usual and, when indicated, mice were
injected twice per day with a 300 mg/kg body weight DMKG in saline solution.
High-fat diet treatment. Eight-week-old atg4b− /− and their corresponding
WT littermates were fed a high-fat diet containing 42% fat (Harlan TD 88137; Zeiss).
Mice were weighted once a week for all the experiment. For spermidine
administration, WT animals (C57BL/6 J) were intraperitoneally-injected daily with a
dose of 50 mg/kg in PBS, as previously reported.27
Sucrose supplementation treatment. Eight-week-old atg4b− /− and WT
mice were fed with standard rodent diet and were given a 30% sucrose solution in
tap water to induce metabolic syndrome, as previously described.42
Histological analysis of tissues. Tissues were harvested and further fixed
with 10% neutral-buffered formalin solution (Sigma-Aldrich, St. Louis, MO, USA) and
left overnight at 4 °C. After that, tissues were dehydrated, embedded in paraffin, cut
and transferred into appropriate porta-slides. Slides were then deparaffinized and
rehydrated. For immunohistochemistry, slides were blocked in 5% BSA (Sigma) for
10 min, incubated with primary antibodies for 1 h at 37 °C, washed in PBS,
incubated for 40 min with secondary antibodies, thoroughly washed in water, and
mounted. For cryosections, tissue samples were embedded in Tissue-Tek OCT
compound (Sakura Finetechnical Co. Ltd., Tokyo, Japan) and stored at − 80 °C.
Samples were then sectioned at 5 mm thickness with cryostat (CM3050 S, Leica).
Cryosections were stained with Oil Red O to detect triglycerides. For histology
analysis, deparaffinized sections were stained with hematoxylin and eosin, Periodic
acid–Schiff (PAS) and Masson’s Trichrome. Liver tissue sections were analyzed for
inflammatory activity and steatosis. For immunofluorescence analyses, images of
immunolabeled samples were obtained at room temperature with a laser-scanning
confocal microscope (TCS-SP2-AOBS; Leica) Relative β-cell mass was estimated
by point counting after insulin IHC. An average of 7000 points/mouse was counted.
The number of test points was chosen to set the probable error of volume density to
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less than 10% of the calculated value.43 Histological inflammatory scores were
evaluated as follows: 0, no inflammation; 1, minimal or mild focal inflammation (few
neutrophils/lymphocytes); 2, multiple focal points (numerous neutrophils/lympho-
cytes); 3, diffuse infiltrate of neutrophils/lymphocytes of severe intensity. For the
analysis of hepatic steatosis, a minimum of 100 hepatocytes per field in 5
independent fields per sample were analyzed. Those hepatocytes whose cytoplasm
was mainly occupied by lipid droplets were considered steatotic hepatocytes.
Pancreatic tissue sections were analyzed for necrosis of pancreatic islets as follows:
0, absence of necrosis; 1, vascular dilation; 2, mild necrosis; 3, moderate and focal
or multifocal necrosis; 4, moderate and diffuse necrosis; 5, severe and
focal/multifocal necrosis; 6, severe and diffuse necrosis.
Glucose and insulin tolerance test. Prior to studies, mice were fasted
overnight. For intraperitoneal glucose tolerance test (IPGTT), mice received an
intraperitoneal injection of glucose (2 g/kg body weight). In intraperitoneal insulin
tolerance test (IPITT) studies, mice were intraperitoneally-injected a dose of 0.75 U
of insulin per kg of body weight. Blood glucose levels were determined as
described above.
Metabolic measurements. Metabolic parameters such as VO2, VCO2 and
energy expenditure were obtained using the comprehensive lab animal monitoring
system (Oxymax CLAMS, Columbus Instruments, Columbus, OH, USA) and
analyzed following manufacturer's instruction. Mice were monitored for 48 h and the
first 24 h were discarded in the analysis, considering them as acclimation period.
Induction of diabetes. Streptozotocin (STZ; Sigma-Aldrich) was dissolved in
0.1 M sodium citrate buffer pH 4.5 immediately before its use to avoid degradation.
Mice were fasted for 4 h and injected intraperitoneally the appropriate amount of the
STZ solution for a final dosage of 150 mg/kg. Animals were supplied with 10%
sucrose water overnight to avoid sudden hypoglycemia post injection, blood glucose
was measured as described above.
Blood and plasma parameters. Animals were fasted overnight and used
for measurements of blood and plasma parameters. Blood glucose was measured
with Accu-Chek glucometer (Roche Diagnostics, Barcelona, Spain) using blood
from the tail vein. For all the other parameters, blood was extracted from facial vein
after anesthetizing mice with halothane. Blood was immediately centrifuged at
2000 rpm in a refrigerated microfuge at 4 °C for 15 min. Supernatant (plasma) was
kept at − 80 °C until further analyses. For plasma insulin, leptin and adiponectin
measurements, we used Millipore ELISA Kits. All protocols were performed
according to manufacturer´s instructions.
Figure 8 Autophagic potential influences adaptability to stress. Autophagy pathway is active in all eukaryotic cells at a basal rate, which contributes to the maintenance of
cellular homeostasis. This basal autophagic activity can be further increased in response to intracellular or extracellular stimuli, including distinct forms of stress at the cell, tissue
or organism level.1 In wild-type mice, autophagy mitigates the detrimental effects of stress, from cellular to organismal level. Contrarily, a total autophagy impairment (as it is the
case in mutant mice lacking Atg3, Atg5 or Atg7) impacts cellular homeostasis, especially in non-proliferating cells, which progressively accumulate cellular damage in the absence
of autophagy.45 Eventually, these defects impact tissue-specific functions although the precise consequences and severity of autophagy impairment are variable among different
tissues.11 At the organismal level, a total loss of autophagy leads to perinatal death.2,10 Interestingly, a partial reduction of autophagic potential as that in Atg4b-deficient mice does
not compromise organism viability, although leads to tissue-specific alterations20,46 and reduced resilience upon stressful conditions. Finally, the pharmacological stimulation of
autophagy (by the treatment with spermidine, for example) increases basal levels of the process, which improves tissue fitness and leads to a reduced sensitivity to environmental
stressors, including high-fat diet
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Fibroblasts extraction and culture. MEFs were extracted from E13
embryos. Briefly, embryos were sterilized with ethanol, washed with PBS and
triturated with razor blades. Samples were then incubated in DMEM (Gibco-
Invitrogen, Carlsbad, CA, USA) overnight at 37 °C and 5% CO2. The next day,
cultured cells were trypsinized, filtered and washed. Finally, MEFs were incubated at
37 °C and 5% CO2 and used for the corresponding experiments. For autophagy
induction, MEFs were cultured during 4 h with 250 nM Torin (S2827, Selleckchem,
Houston, TX, USA), 100 μM spermidine (Sigma-Aldrich), 100 μM Resveratrol
(Sigma-Aldrich) in supplemented DMEM. For autophagy experiments, MEFs were
cultured during 4 h in the presence of 100 nM Bafilomycin A1 (BML-CM110, Enzo
Life Sciences, Farmingdale, NY, USA).
Mouse experiments and tissue processing. Mice were were housed in
a temperature controlled environment with 12 h light/dark cycles and received food
and water ad libitum. Mice were injected intraperitoneally with 50 mg/kg Spd or
25 mg/kg resveratrol 6 h before anesthetization and killing. For autophagy flux
experiments, mied were IP injected a 30 mg/kg single dose of Leupeptin, as
previously reported.44 Mice tissues were immediately frozen in liquid nitrogen after
extraction and homogenized in a 20 mM Tris buffer (pH 7.4) containing 150 mM
NaCl, 1% Triton X-100, 10 mM EDTA and Complete protease inhibitor cocktail
(Roche Applied Science). Tissue extracts were then centrifuged at 12 000 G at 4 °C
and supernatants were collected. Protein concentration in the supernatants was
evaluated by the bicinchoninic acid technique (BCA protein assay kit, Pierce
Biotechnology, Rockford, IL, USA).
Statistical analyses. Unless otherwise mentioned, experiments were
performed in triplicate and repeated at least twice. Data were analyzed using the
GraphPad Prism 5 software and statistical significance was assessed by means of
two-tailed Student’s t-test or ANOVA tests, as appropriate (*Po0.05, **Po0.01,
n≥ 3).
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